Mölsä P K
Paimio Settlement for the Mentally Handicapped, Naskarla, Finland.
J Ment Defic Res. 1990 Aug;34 ( Pt 4):379-83. doi: 10.1111/j.1365-2788.1990.tb01548.x.
The institutionalized population and staff in a centre for the mentally retarded were tested retrospectively, and 1.6% hepatitis Bs antigen and 0.6% hepatitis Be antigen carriers were found among persons with mental retardation. The 40 subjects, residents and staff, with most risk of acquiring hepatitis B were given vaccination. The immunogenicity of the H-B-Vax vaccine was followed up prospectively and, in 7.5% of the vaccinated persons, even re-vaccination gave an unsatisfactory result.
对一所智障人士中心的住院人员及工作人员进行了回顾性检测，结果发现智障人群中乙肝表面抗原携带者占1.6%，乙肝e抗原携带者占0.6%。对40名感染乙肝风险最高的住院人员及工作人员进行了疫苗接种。对H-B-Vax疫苗的免疫原性进行了前瞻性跟踪，结果发现，在7.5%的接种者中，即使再次接种也未取得理想效果。
